Arrogene

Arrogene

Arrogene

Arrogene, Inc. is working on building a pipeline of new generation nanomedicines capable of targeting cancer cells and specifically preventing tumor growth.
Founded
2007
Raised
$1M
Follow us
Alexa global traffic share
Latest funding
$750,000
Debt financing - 2016
$250,000
Debt financing - 2015
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Arrogene makes some noise.